Skip to content
value.today
Total raised
$27 M
2 rounds on record
Latest round
$2 M
Jul 2017
First round on record
Aug 2014
Today
Private
See the company page

Metabolix, Inc. is listed today as Yield10 Bioscience, Inc.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Metabolix, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2017$2 MNo. 2$2 to $10 million

Metabolix, Inc.: Raise no. 2, Jul 2017

Investors in this round

11 investors had bought by the notice of Jul 14, 2017: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Metabolix, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$125,573
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Charles B. Haaser · Executive Officer
  • Kristi D. Snell · Executive Officer
  • Lynne H. Brum · Executive Officer
  • Oliver P. Peoples · Executive Officer, Director
  • Anthony J. Sinskey · Director
  • Joseph N. Shaulson · Director
  • Peter N. Kellogg · Director
  • Richard W. Hamilton · Director
  • Robert L. Van Nostrand · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalmann & Co. Inc. (CRD 505) · New York, New YorkSold in CT, IL, NJ, NY, TX

Remarks in the notice

  • On fees: “Sales commissions relates to commissions for the sale of common stock in the concurrent registered offering.”
  • On the amounts: “The total offering amount includes the concurrent registered offering of common stock.”

Signed by Oliver P. Peoples, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 14, 2017. Read the notice at the SEC.

equity, optionsSEC
Aug 2014$25 MNo. 1$10 to $50 million

Metabolix, Inc.: Raise no. 1, Aug 2014

Investors in this round

27 investors had bought by the notice of Sep 8, 2014: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 6 investors are named for Metabolix, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Johan D. van Walsem · Executive Officer · Chief Operating Officer
  • Joseph D. Hill · Executive Officer · Chief Financial Officer and Treasurer
  • Joseph Shaulson · Executive Officer, Director · President, Chief Executive Officer and Director
  • Lynne D. Brum · Executive Officer · Vice President, Marketing and Corporate Communications
  • Oliver P. Peoples · Executive Officer, Director · Chief Scientific Officer and Director
  • Sarah P. Cecil · Executive Officer · General Counsel and Secretary
  • Anthony J. Sinskey · Director
  • Celeste N. Beeks Mastin · Director
  • Matthew J. Strobeck · Director
  • Peter N. Kellogg · Director
  • Robert L. Van Nostrand · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sarah P. Cecil, General Counsel and Secretary. Source: SEC Form D, newest notice filed Sep 8, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Metabolix, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2017).

    SEC Form D · Jul 2017

  • The industry group it chose in its notices: Other.

    SEC Form D · Jul 2017

That is all the official record says: Metabolix, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Metabolix, Inc. are on record.

Investors#

6 named in official filings. Open an investor to see everything it has backed.

Investors in Metabolix, Inc.
InvestorKindAmountRoundRoleSource
Birchview Capital GP, LLCFund or asset managernot statednot statedHeld Series B preferred stock, director (Form 3, 2014)SEC Form 3
Birchview Capital, LPFund or asset managernot statednot statedHeld Series B preferred stock, director (Form 3, 2014)SEC Form 3
Birchview Fund LLCFund or asset managernot statednot statedHeld Series B preferred stock, director (Form 3, 2014)SEC Form 3
Birchview Partners, LLCFund or asset managernot statednot statedHeld Series B preferred stock, director (Form 3, 2014)SEC Form 3
Schuler Family FoundationOthernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2014)SEC Form 3
William P. ScullyPersonnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 27 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Metabolix, Inc.
NameRoleNamed in
Charles B. HaaserExecutive officerJul 2017
Kristi D. SnellExecutive officerJul 2017
Lynne H. BrumExecutive officerJul 2017
Oliver P. PeoplesExecutive officerJul 2017
Johan D. van WalsemChief Operating OfficerSep 2014
Joseph D. HillChief Financial Officer and TreasurerSep 2014
Joseph ShaulsonPresident, Chief Executive Officer and DirectorSep 2014
Lynne D. BrumVice President, Marketing and Corporate CommunicationsSep 2014
Sarah P. CecilGeneral Counsel and SecretarySep 2014
Anthony J. SinskeyDirectorJul 2017
Joseph N. ShaulsonDirectorJul 2017
Oliver P. PeoplesDirectorJul 2017
Peter N. KelloggDirectorJul 2017
Richard W. HamiltonDirectorJul 2017
Robert L. Van NostrandDirectorJul 2017
Celeste N. Beeks MastinDirectorSep 2014
Joseph ShaulsonPresident, Chief Executive Officer and DirectorSep 2014
Matthew J. StrobeckDirectorSep 2014

About

American company.